In Vitro Diagnostics Market (Technology Type: Point-of-care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, Coagulation & Hemostasis, and Others; Application: Drug Testing, Infec

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,795	222 Pages	Transparency Market Research Pvt. Ltd.	February, 2022	TNPR17067625

Best Price Guarantee
Price	from $5,795
Length	222 Pages
Publisher	Transparency Market Research Pvt. Ltd.
Published Date	February, 2022
SKU	TNPR17067625

In Vitro Diagnostics Market (Technology Type: Point-of-care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, Coagulation & Hemostasis, and Others; Application: Drug Testing, Infectious Diseases, Oncology, Metabolic Diseases, Autoimmune Diseases, and Others; and End-user: Diagnostic Laboratories, Hospitals, Academic & Research Centers, Home Care, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

In Vitro Diagnostics Market – Scope of Report
TMR’s report on the global in vitro diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global in vitro diagnostics market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vitro diagnostics market from 2021 to 2028.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in vitro diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vitro diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global in vitro diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vitro diagnostics market.

The report delves into the competition landscape of the global in vitro diagnostics market. Key players operating in the global in vitro diagnostics market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vitro diagnostics market profiled in this report.

Key Questions Answered in Global In Vitro Diagnostics Market Report
What will be the revenue generated in the global in vitro diagnostics market across all geographies during the forecast period?
What are key trends in the in vitro diagnostics market?
What are major drivers, restraints, and opportunities in the market?
Which region is set to expand at the maximum CAGR during the forecast period?
Which segment of the global in vitro diagnostics market will generate the maximum revenue globally by 2028?
Which segment will expand at the maximum CAGR during the forecast period?
In Vitro Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global in vitro diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in vitro diagnostics market in terms of technology type, application, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro diagnostics market.

Companies Mentioned

Competition Matrix
F. Hoffmann-La Roche Ltd.
Danaher
Siemens Healthineers
bioMérieux SA
Abbott
Diasorin
Meridian Bioscience, Inc.
Ortho-Clinical Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
Sysmex Corporation
Other Prominent Players

1. Preface: 1.1. Market Definition and Scope; 1.2. Market Segmentation; 1.3. Key Research Objectives; 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Diagnostics Market
4. Market Overview: 4.1. Introduction; 4.1.1. Application Definition; 4.1.2. Industry Evolution / Developments; 4.2. Overview; 4.3. Market Dynamics; 4.3.1. Drivers; 4.3.2. Restraints; 4.3.3. Opportunities; 4.4. Global In Vitro Diagnostics Market Analysis and Forecast, 2017–2028; 4.4.1. Market Revenue Projections (US$ Mn); 4.4.2. Market Volume/Unit Shipments Projections; 4.5. Porter’s Five Force Analysis
5. Key Insights: 5.1. Key Mergers and Acquisition; 5.2. Key Success Factor for Top 3 Players; 5.3. Regulatory Scenario; 5.4. Technology Assessment
6. Global In Vitro Diagnostics Market Analysis and Forecast, by Application: 6.1. Introduction & Definition; 6.2. Key Findings / Developments; 6.3. Market Value & Volume Forecast, by Application, 2017–2028; 6.3.1. Drug Testing; 6.3.2. Infectious Diseases; 6.3.3. Oncology; 6.3.4. Metabolic Diseases; 6.3.5. Autoimmune Diseases; 6.3.6. Others; 6.4. Market Attractiveness Analysis, by Application
7. Global In Vitro Diagnostics Market Analysis and Forecast, by End-user: 7.1. Introduction & Definition; 7.2. Key Findings / Developments; 7.3. Market Value & Volume Forecast, by End-user, 2017–2028; 7.3.1. Diagnostic Laboratories; 7.3.2. Hospitals; 7.3.3. Academic & Research Centers; 7.3.4. Home Care; 7.3.5. Others; 7.4. Market Attractiveness Analysis, by End-user
8. Global In Vitro Diagnostics Market Analysis and Forecast, by Technology Type: 8.1. Introduction & Definition; 8.2. Key Findings / Developments; 8.3. Market Value & Volume Forecast, by Technology Type, 2017–2028; 8.3.1. Point-of-care; 8.3.2. Molecular Diagnostics; 8.3.3. Immunoassays; 8.3.4. Clinical Chemistry; 8.3.5. Whole Blood Glucose Monitoring; 8.3.6. Hematology; 8.3.7. Clinical Microbiology; 8.3.8. Coagulation & Hemostasis; 8.3.9. Others; 8.4. Market Attractiveness Analysis, by Technology Type
9. Global In Vitro Diagnostics Market Analysis and Forecast, by Region: 9.1. Key Findings; 9.2. Market Value & Volume Forecast, by Region; 9.2.1. North America; 9.2.2. Europe; 9.2.3. Asia Pacific; 9.2.4. Latin America; 9.2.5. Middle East & Africa; 9.3. Market Attractiveness Analysis, by Region
10. North America In Vitro Diagnostics Market Analysis and Forecast: 10.1. Introduction; 10.1.1. Key Findings; 10.2. Market Value & Volume Forecast, by Application, 2017–2028; 10.2.1. Drug Testing; 10.2.2. Infectious Diseases; 10.2.3. Oncology; 10.2.4. Metabolic Diseases; 10.2.5. Autoimmune Diseases; 10.2.6. Others; 10.3. Market Value & Volume Forecast, by End-user, 2017–2028; 10.3.1. Diagnostic Laboratories; 10.3.2. Hospitals; 10.3.3. Academic & Research Centers; 10.3.4. Home Care; 10.3.5. Others; 10.4. Market Value & Volume Forecast, by Technology Type, 2017–2028; 10.4.1. Point-of-care; 10.4.2. Molecular Diagnostics; 10.4.3. Immunoassays; 10.4.4. Clinical Chemistry; 10.4.5. Whole Blood Glucose Monitoring; 10.4.6. Hematology; 10.4.7. Clinical Microbiology; 10.4.8. Coagulation & Hemostasis; 10.4.9. Others; 10.5. Market Value & Volume Forecast, by Country, 2017–2028; 10.5.1. U.S.; 10.5.2. Canada; 10.6. Market Attractiveness Analysis; 10.6.1. By Application; 10.6.2. By End-user; 10.6.3. By Technology Type; 10.6.4. By Country
11. Europe In Vitro Diagnostics Market Analysis and Forecast: 11.1. Introduction; 11.1.1. Key Findings; 11.2. Market Value & Volume Forecast, by Application, 2017–2028; 11.2.1. Drug Testing; 11.2.2. Infectious Diseases; 11.2.3. Oncology; 11.2.4. Metabolic Diseases; 11.2.5. Autoimmune Diseases; 11.2.6. Others; 11.3. Market Value & Volume Forecast, by End-user, 2017–2028; 11.3.1. Diagnostic Laboratories; 11.3.2. Hospitals; 11.3.3. Academic & Research Centers; 11.3.4. Home Care; 11.3.5. Others; 11.4. Market Value & Volume Forecast, by Technology Type, 2017–2028; 11.4.1. Point-of-care; 11.4.2. Molecular Diagnostics; 11.4.3. Immunoassays; 11.4.4. Clinical Chemistry; 11.4.5. Whole Blood Glucose Monitoring; 11.4.6. Hematology; 11.4.7. Clinical Microbiology; 11.4.8. Coagulation & Hemostasis; 11.4.9. Others; 11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028; 11.5.1. Germany; 11.5.2. U.K.; 11.5.3. France; 11.5.4. Spain; 11.5.5. Italy; 11.5.6. Rest of Europe; 11.6. Market Attractiveness Analysis; 11.6.1. By Application; 11.6.2. By End-user; 11.6.3. By Technology Type; 11.6.4. By Country/Sub-region
12. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast: 12.1. Introduction; 12.1.1. Key Findings; 12.2. Market Value & Volume Forecast, by Application, 2017–2028; 12.2.1. Drug Testing; 12.2.2. Infectious Diseases; 12.2.3. Oncology; 12.2.4. Metabolic Diseases; 12.2.5. Autoimmune Diseases; 12.2.6. Others; 12.3. Market Value & Volume Forecast, by End-user, 2017–2028; 12.3.1. Diagnostic Laboratories; 12.3.2. Hospitals; 12.3.3. Academic & Research Centers; 12.3.4. Home Care; 12.3.5. Others; 12.4. Market Value & Volume Forecast, by Technology Type, 2017–2028; 12.4.1. Point-of-care; 12.4.2. Molecular Diagnostics; 12.4.3. Immunoassays; 12.4.4. Clinical Chemistry; 12.4.5. Whole Blood Glucose Monitoring; 12.4.6. Hematology; 12.4.7. Clinical Microbiology; 12.4.8. Coagulation & Hemostasis; 12.4.9. Others; 12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028; 12.5.1. China; 12.5.2. Japan; 12.5.3. India; 12.5.4. Australia & New Zealand; 12.5.5. Rest of Asia Pacific; 12.6. Market Attractiveness Analysis; 12.6.1. By Application; 12.6.2. By End-user; 12.6.3. By Technology Type; 12.6.4. By Country/Sub-region
13. Latin America In Vitro Diagnostics Market Analysis and Forecast: 13.1. Introduction; 13.1.1. Key Findings; 13.2. Market Value & Volume Forecast, by Application, 2017–2028; 13.2.1. Drug Testing; 13.2.2. Infectious Diseases; 13.2.3. Oncology; 13.2.4. Metabolic Diseases; 13.2.5. Autoimmune Diseases; 13.2.6. Others; 13.3. Market Value & Volume Forecast, by End-user, 2017–2028; 13.3.1. Diagnostic Laboratories; 13.3.2. Hospitals; 13.3.3. Academic & Research Centers; 13.3.4. Home Care; 13.3.5. Others; 13.4. Market Value & Volume Forecast, by Technology Type, 2017–2028; 13.4.1. Point-of-care; 13.4.2. Molecular Diagnostics; 13.4.3. Immunoassays; 13.4.4. Clinical Chemistry; 13.4.5. Whole Blood Glucose Monitoring; 13.4.6. Hematology; 13.4.7. Clinical Microbiology; 13.4.8. Coagulation & Hemostasis; 13.4.9. Others; 13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028; 13.5.1. Brazil; 13.5.2. Mexico; 13.5.3. Rest of Latin America; 13.6. Market Attractiveness Analysis; 13.6.1. By Application; 13.6.2. By End-user; 13.6.3. By Technology Type; 13.6.4. By Country/Sub-region
14. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast: 14.1. Introduction; 14.1.1. Key Findings; 14.2. Market Value & Volume Forecast, by Application, 2017–2028; 14.2.1. Drug Testing; 14.2.2. Infectious Diseases; 14.2.3. Oncology; 14.2.4. Metabolic Diseases; 14.2.5. Autoimmune Diseases; 14.2.6. Others; 14.3. Market Value & Volume Forecast, by End-user, 2017–2028; 14.3.1. Diagnostic Laboratories; 14.3.2. Hospitals; 14.3.3. Academic & Research Centers; 14.3.4. Home Care; 14.3.5. Others; 14.4. Market Value & Volume Forecast, by Technology Type, 2017–2028; 14.4.1. Point-of-care; 14.4.2. Molecular Diagnostics; 14.4.3. Immunoassays; 14.4.4. Clinical Chemistry; 14.4.5. Whole Blood Glucose Monitoring; 14.4.6. Hematology; 14.4.7. Clinical Microbiology; 14.4.8. Coagulation & Hemostasis; 14.4.9. Others; 14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028; 14.5.1. GCC Countries; 14.5.2. South Africa; 14.5.3. Rest of Middle East & Africa; 14.6. Market Attractiveness Analysis; 14.6.1. By Application; 14.6.2. By End-user; 14.6.3. By Technology Type; 14.6.4. By Country/Sub-region
15. Competition Landscape: 15.1. Market Player - Competition Matrix (by tier and size of companies); 15.2. Market Share Analysis, by Company, 2020; 15.3. Market Footprint Analysis; 15.3.1. By Region; 15.3.2. By Application Type; 15.4. Competitive Business Strategies; 15.5. Company Profiles; 15.5.1. Competition Matrix; 15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.1.2. Product Portfolio; 15.5.1.3. SWOT Analysis; 15.5.1.4. Strategic Overview; 15.5.2. F. Hoffmann-La Roche Ltd.; 15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.2.2. Product Portfolio; 15.5.2.3. SWOT Analysis; 15.5.2.4. Strategic Overview; 15.5.3. Danaher; 15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.3.2. Product Portfolio; 15.5.3.3. SWOT Analysis; 15.5.3.4. Strategic Overview; 15.5.4. Siemens Healthineers; 15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.4.2. Product Portfolio; 15.5.4.3. SWOT Analysis; 15.5.4.4. Strategic Overview; 15.5.5. bioMérieux SA; 15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.5.2. Product Portfolio; 15.5.5.3. SWOT Analysis; 15.5.5.4. Strategic Overview; 15.5.6. Abbott; 15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.6.2. Product Portfolio; 15.5.6.3. SWOT Analysis; 15.5.6.4. Strategic Overview; 15.5.7. Diasorin; 15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.7.2. Product Portfolio; 15.5.7.3. SWOT Analysis; 15.5.7.4. Strategic Overview; 15.5.8. Meridian Bioscience, Inc.; 15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.8.2. Product Portfolio; 15.5.8.3. SWOT Analysis; 15.5.8.4. Strategic Overview; 15.5.9. Ortho-Clinical Diagnostics, Inc.; 15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.9.2. Product Portfolio; 15.5.9.3. SWOT Analysis; 15.5.9.4. Strategic Overview; 15.5.10. Thermo Fisher Scientific, Inc.; 15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.10.2. Product Portfolio; 15.5.10.3. SWOT Analysis; 15.5.10.4. Strategic Overview; 15.5.11. Sysmex Corporation; 15.5.11.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.11.2. Product Portfolio; 15.5.11.3. SWOT Analysis; 15.5.11.4. Strategic Overview; 15.5.12. Other Prominent Players; 15.5.12.1. Company Overview (HQ, Business Segments, Employee Strength); 15.5.12.2. Product Portfolio; 15.5.12.3. SWOT Analysis; 15.5.12.4. Strategic Overview